Nature
6 months agoData science
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia - Nature
Propionic acidemia is a rare disorder with potentially life-threatening metabolic decompensation events.
mRNA-3927 therapy showed promising results in reducing the risk of metabolic decompensation events in participants. [ more ]